Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-26-002336
Filing Date
2026-03-17
Accepted
2026-03-17 17:00:58
Documents
40
Period of Report
2026-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbsv_10q.htm   iXBRL 10-Q 589783
2 CERTIFICATION pbsv_ex311.htm EX-31.1 11889
3 CERTIFICATION pbsv_ex312.htm EX-31.2 12065
4 CERTIFICATION pbsv_ex321.htm EX-32.1 4279
  Complete submission text file 0001654954-26-002336.txt   2644917

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20260131.xsd EX-101.SCH 21082
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20260131_lab.xml EX-101.LAB 154540
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20260131_cal.xml EX-101.CAL 33571
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20260131_pre.xml EX-101.PRE 119534
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20260131_def.xml EX-101.DEF 41291
44 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_10q_htm.xml XML 317844
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

EIN.: 200653570 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-50956 | Film No.: 26763155
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)